Revisão Revisado por pares

Current treatment options in triple negative breast cancer

2011; IOS Press; Volume: 32; Issue: 1-2 Linguagem: Inglês

10.3233/bd-2010-0304

ISSN

1558-1551

Autores

Eve T. Rodler, Larissa A. Korde, Julie R. Gralow,

Tópico(s)

Advanced Breast Cancer Therapies

Resumo

Triple negative breast cancer (TNBC) refers to a subgroup of breast carcinomas that do not express the estrogen receptor, progesterone receptor, or human epidermal growth factor receptor type 2. This heterogeneous group of tumors has significant over

Referência(s)
Altmetric
PlumX